We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

128 hedge funds and large institutions have $75.2M invested in Ampio Pharmaceuticals Inc. in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

561% more call options, than puts

Call options by funds: $2.71M | Put options by funds: $410K

90% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 20

46% more capital invested

Capital invested by funds: $51.5M → $75.2M (+$23.7M)

22% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 23

16% more funds holding

Funds holding: 110 → 128 (+18)

Holders
128
Holders Change
+18
Holders Change %
+16.36%
% of All Funds
2.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
28
Reduced
23
Closed
20
Calls
$2.71M
Puts
$410K
Net Calls
+$2.3M
Net Calls Change
+$811K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$15.4M
2
State Street
State Street
Massachusetts
+$4.91M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.05M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.76M
5
Northern Trust
Northern Trust
Illinois
+$2.69M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.23M
2
HF
HRT Financial
New York
-$839K
3
ECM
ExodusPoint Capital Management
New York
-$817K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$794K
5
Citadel Advisors
Citadel Advisors
Florida
-$662K
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
$101K +$108K +202 New
Balyasny Asset Management
52
Balyasny Asset Management
Illinois
$101K +$35.4K +66 +49%
RJFSA
53
Raymond James Financial Services Advisors
Florida
$98K +$1.07K +2 +1%
UCFA
54
United Capital Financial Advisors
Texas
$93K – – –
IWM
55
IHT Wealth Management
Illinois
$90K +$17.7K +33 +22%
Citadel Advisors
56
Citadel Advisors
Florida
$89K -$662K -1,233 -87%
D.E. Shaw & Co
57
D.E. Shaw & Co
New York
$86K +$92.4K +172 New
ProShare Advisors
58
ProShare Advisors
Maryland
$82K +$88.1K +164 New
TWM
59
Tradition Wealth Management
Minnesota
$80K -$4.83K -9 -5%
BIAS
60
Beacon Investment Advisory Services
New Jersey
$67K – – –
CSS
61
Cubist Systematic Strategies
Connecticut
$62K -$266K -496 -80%
SBIA
62
Sheaff Brock Investment Advisors
Indiana
$62K +$23.1K +43 +54%
AB
63
Amalgamated Bank
New York
$60K +$64.5K +120 New
JWA
64
JFS Wealth Advisors
Pennsylvania
$59K – – –
Commonwealth Equity Services
65
Commonwealth Equity Services
Massachusetts
$59K +$1.07K +2 +2%
CW
66
CreativeOne Wealth
Kansas
$56K +$2.15K +4 +4%
CM
67
Caption Management
Oklahoma
$55K +$58K +108 New
FHA
68
Flagship Harbor Advisors
Massachusetts
$51K +$1.07K +2 +2%
Principal Financial Group
69
Principal Financial Group
Iowa
$51K +$54.2K +101 New
Victory Capital Management
70
Victory Capital Management
Texas
$48K -$1.61K -3 -3%
TW
71
TrinityPoint Wealth
Connecticut
$43K – – –
OC
72
Oppenheimer & Co
New York
$42K – – –
EWA
73
Exencial Wealth Advisors
Oklahoma
$41K – – –
MAM
74
Marotta Asset Management
Virginia
$40.6K – – –
Barclays
75
Barclays
United Kingdom
$40K -$5.91K -11 -12%
1 2
3
4 5

AMPE Hedge Fund Activity: Q2 2021 in Review

128 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2021, worth a combined $75.2M — up 46% from $51.5M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new AMPE positions and 20 closed out — a net gain of 18 holders — while 28 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $15.4M. The largest seller was Millennium Management, exiting entirely with an estimated $3.23M sold.

  • 128 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2021, up from 110 in Q1 2021.
  • Funds reported $75.2M of Ampio Pharmaceuticals Inc. stock for Q2 2021, up 46% quarter-over-quarter.
  • 38 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2021 and 20 closed out, a net change of +18 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2021 was BlackRock, an estimated $15.4M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2021 was Millennium Management, an estimated $3.23M sold.

Based on aggregated 13F filings for Q2 2021.